Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Severe COVID-19
NCT04391101Phase 3Unknown
- Sponsor
- Hospital San Vicente Fundación
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hospital San Vicente Fundación. Primary endpoint: Intrahospital mortality from any cause at 28 days. Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04391101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391101.